{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-002725","form_type":"8-K","ticker":"NVAX","cik":"0001000694","company_name":"NOVAVAX INC","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.364764+00:00","generated_at":"2026-05-16T10:45:27.169291+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"low","headline":"Novavax presents strategic update at J.P. Morgan; 2025 results pending","bullets":["Preliminary financial results for year ended Dec 31, 2025 are being finalized and subject to change.","No specific financial metrics disclosed; presentation focuses on strategic and business updates.","Investor presentation delivered at 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026.","Company cautions that actual results may differ materially from preliminary data."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-002725","json":"https://secwatch.observer/filing/0001104659-26-002725.json","markdown":"https://secwatch.observer/filing/0001104659-26-002725.md","text":"https://secwatch.observer/filing/0001104659-26-002725.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926002725/0001104659-26-002725-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926002725/tm262897d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:45:27.169291+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}